122 related articles for article (PubMed ID: 2517980)
1. Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo.
Timár J
Acta Physiol Hung; 1989; 74(3-4):259-66. PubMed ID: 2517980
[TBL] [Abstract][Full Text] [Related]
2. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
Timár J; Knoll B
Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):50-60. PubMed ID: 3083795
[TBL] [Abstract][Full Text] [Related]
3. The effect of (-) deprenyl (selegiline) on different behavioral changes induced by dopamine agonists in the rat.
Timar J; Knoll B; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):659-66. PubMed ID: 2908366
[TBL] [Abstract][Full Text] [Related]
4. Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
Youdim MB; Tipton KF
Parkinsonism Relat Disord; 2002 Mar; 8(4):247-53. PubMed ID: 12039419
[TBL] [Abstract][Full Text] [Related]
5. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
Timar J; Knoll B; Knoll J
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
[TBL] [Abstract][Full Text] [Related]
8. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
Knoll J
Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
[TBL] [Abstract][Full Text] [Related]
9. 2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.
Kitanaka J; Kitanaka N; Tatsuta T; Takemura M
Pharmacol Biochem Behav; 2005 Nov; 82(3):488-94. PubMed ID: 16298423
[TBL] [Abstract][Full Text] [Related]
10. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors.
Bergman J; Yasar S; Winger G
Psychopharmacology (Berl); 2001 Dec; 159(1):21-30. PubMed ID: 11797065
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference.
Meyerson LR; Fuller RW
Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):581-4. PubMed ID: 30122
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
13. Gonadal influences on the inhibition of monoamine oxidase type B activity.
Vaccari A; Biassoni R
J Neurosci Res; 1982; 8(1):13-9. PubMed ID: 6816948
[TBL] [Abstract][Full Text] [Related]
14. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
Magyar K; Szende B
Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
[TBL] [Abstract][Full Text] [Related]
15. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
Knoll J
J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
[TBL] [Abstract][Full Text] [Related]
16. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.
Zsilla G; Földi P; Held G; Székely AM; Knoll J
Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology of (-)deprenyl.
Knoll J
J Neural Transm Suppl; 1986; 22():75-89. PubMed ID: 3097262
[TBL] [Abstract][Full Text] [Related]
18. Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors.
Ortmann R; Schaub M; Felner A; Lauber J; Christen P; Waldmeier PC
Psychopharmacology (Berl); 1984; 84(1):22-7. PubMed ID: 6436886
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences.
Yoshida T; Oguro T; Kuroiwa Y
Xenobiotica; 1987 Aug; 17(8):957-63. PubMed ID: 3118583
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of deprenyl in aged rats.
Drago F; Continella G; Spadaro F; Cavaliere S; Scapagnini U
Funct Neurol; 1986; 1(2):165-74. PubMed ID: 3111946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
